1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cardiovascular Diseases in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Grabrucker, AM; Hans, S; Harishkumar, R; Lordan, R; Stanton, JE; Zabetakis, I | 1 |
| English, CJ; Jones, M; Lohning, AE; Mayr, HL; Reidlinger, DP | 1 |
| Bhattacharjee, A; Gurung, AB | 1 |
| Antonopoulou, S; Fragopoulou, E; Nomikos, T; Panagiotakos, DB | 1 |
| Jiang, Q; Wang, C; Xia, W; Xu, Y; Yang, Y; Yin, S; Yu, P | 1 |
| Antonopoulou, S; Detopoulou, P; Fragopoulou, E; Nomikos, T; Panagiotakos, DB; Stamatakis, G; Yannakoulia, M | 1 |
| Montagni, M; Parente, R; Ridolo, E; Triggiani, M | 1 |
| Megson, IL; Whitfield, PD; Zabetakis, I | 1 |
| Cederholm, A; Concha, H; Frostegård, J; Hua, X; Su, J; Svenungsson, E | 1 |
| Antonopoulou, S; Demopoulos, CA; Fragopoulou, E; Iatrou, C; Tsantila, N; Tsoupras, AB | 1 |
| Calabresi, L; Franceschini, G; Gomaraschi, M | 1 |
| Holmes, A; Loscalzo, J; Willoughby, S | 1 |
| Brouckaert, P; Buys, E; Cauwels, A; Janssen, B; Sips, P | 1 |
| Collot-Teixeira, S; Martin, J; McGregor, JL; McGregor, L | 1 |
| Tselepis, AD; Tsimikas, S; Tsironis, LD | 1 |
| Denizot, Y; Nathan, N | 1 |
| Guo, ZM; Liu, CT; Peters, CJ; Qian, C | 1 |
| Fletcher, JR | 1 |
| Beilin, LJ; Burke, V; Mori, TA; Morris, J; Ritchie, J | 1 |
| Afanasjeva, G; Avdonin, P; Baskova, I; Berezhnoy, S; Gabbasov, Z; Popov, E; Zavalova, L | 1 |
| Alloatti, G; Camussi, G; Montrucchio, G | 1 |
| Stafforini, DM; Tjoelker, LW | 1 |
| Banks-Schlegel, SP; Barnes, PJ; Henson, PM | 1 |
| Bugelski, PJ; Esser, KM; Feuerstein, G; Griswold, DE; Hallenbeck, JM; Hillegass, LM; Lysko, PG; Rabinovici, R; Yue, TL | 1 |
| Fedorov, NA | 1 |
| Gabryelewicz, A; Rydzewska, G | 1 |
| McManus, LM | 1 |
13 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiovascular Diseases
| Article | Year |
|---|---|
Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients.
Topics: Atherosclerosis; Cardiovascular Diseases; Fibrinolytic Agents; Humans; Nutrients; Platelet Activating Factor; Receptors, G-Protein-Coupled | 2022 |
Mediterranean diet and platelet-activating factor; a systematic review.
Topics: Cardiovascular Diseases; Chronic Disease; Diet, Mediterranean; Humans; Inflammation Mediators; Platelet Activating Factor | 2018 |
Anaphylaxis and cardiovascular diseases: a dangerous liaison.
Topics: Anaphylaxis; Cardiovascular Diseases; Histamine; Humans; Inflammation; Mastocytosis; Platelet Activating Factor; Prostaglandins | 2014 |
Lipids and cardiovascular disease: where does dietary intervention sit alongside statin therapy?
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Cholesterol; Diet; Fatty Acids, Omega-3; Fishes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Meta-Analysis as Topic; Olive Oil; Platelet Activating Factor; Platelet Aggregation; Randomized Controlled Trials as Topic; Seafood | 2016 |
Endothelial protection by high-density lipoproteins: from bench to bedside.
Topics: Blood Coagulation; Cardiovascular Diseases; Endothelins; Endothelium, Vascular; Epoprostenol; Humans; Inflammation; Lipoproteins, HDL; Nitric Oxide; Platelet Activating Factor | 2003 |
Platelets and cardiovascular disease.
Topics: Blood Platelets; Cardiovascular Diseases; Diabetes Complications; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Smoking | 2002 |
The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes.
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular Agents; Cardiovascular Diseases; Cell Adhesion Molecules; Cell Communication; Chemokines; Endothelial Cells; Genomics; Humans; Inflammation; Intercellular Adhesion Molecule-1; Macrophages; Membrane Glycoproteins; Monocytes; P-Selectin; Platelet Activating Factor; Platelet Endothelial Cell Adhesion Molecule-1; Signal Transduction; Vascular Cell Adhesion Molecule-1 | 2007 |
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apolipoprotein B-100; Atherosclerosis; Cardiovascular Diseases; Humans; Lipoprotein(a); Oxidation-Reduction; Phospholipases A2; Phospholipids; Platelet Activating Factor | 2007 |
Eicosanoids. Critical agents in the physiological process and cellular injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Eicosanoids; Gastrointestinal Diseases; General Surgery; Humans; Lipoxygenase; Molecular Biology; Phospholipids; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Tumor Necrosis Factor-alpha | 1993 |
Role of platelet-activating factor in cardiovascular pathophysiology.
Topics: Anaphylaxis; Animals; Cardiovascular Diseases; Cells, Cultured; Endothelium, Vascular; Heart; Hemodynamics; Humans; In Vitro Techniques; Microcirculation; Myocardium; Neovascularization, Pathologic; Neovascularization, Physiologic; Organ Specificity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Signal Transduction | 2000 |
Platelet-activating factor acetylhydrolases in health and disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Anti-Inflammatory Agents; Biomarkers; Cardiovascular Diseases; Cell Line; Cells, Cultured; Cloning, Molecular; Erythrocytes; Europe; Gene Expression Regulation; Humans; Inflammation; Isoenzymes; Japan; Mutation; Phospholipases A; Phospholipids; Platelet Activating Factor; Substrate Specificity; Tumor Cells, Cultured | 2000 |
[Platelet activating factor (PAF) and its inhibitors].
Topics: Anaphylaxis; Cardiovascular Diseases; Digestive System Diseases; Histamine H1 Antagonists; Histamine Release; Humans; Lignans; Lignin; Platelet Activating Factor; Terpenes | 1988 |
Pathobiology of platelet-activating factors.
Topics: Animals; Cardiovascular Diseases; Humans; Inflammation; Lung Diseases; Platelet Activating Factor | 1986 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiovascular Diseases
| Article | Year |
|---|---|
Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease.
Topics: Adult; Animals; Blood Platelets; Cardiovascular Diseases; Collagen; Diet; Diet, Fat-Restricted; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Omega-3; Fish Oils; Fishes; Humans; Male; Middle Aged; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Thromboxane B2 | 1997 |
14 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiovascular Diseases
| Article | Year |
|---|---|
Interrelationships among platelet-activating factor and lipoprotein-associated phospholipase A
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Female; Heart Disease Risk Factors; Humans; Male; Platelet Activating Factor; Risk Factors | 2023 |
Met117 oxidation leads to enhanced flexibility of cardiovascular biomarker- lipoprotein- associated phospholipase A
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Apoproteins; Biomarkers; Cardiovascular Diseases; Humans; Hydrogen Bonding; Methionine; Molecular Docking Simulation; Molecular Dynamics Simulation; Oxidation-Reduction; Platelet Activating Factor; Principal Component Analysis; Substrate Specificity; Thermodynamics | 2018 |
Anti-platelet-activating factor, antibacterial, and antiradical activities of lipids extract from silver carp brain.
Topics: Animals; Anti-Bacterial Agents; Biphenyl Compounds; Blood Platelets; Brain Chemistry; Cardiovascular Diseases; Carps; Escherichia coli; Free Radical Scavengers; Lipids; Picrates; Platelet Activating Factor; Rabbits; Staphylococcus aureus; Tissue Extracts | 2013 |
The relation of diet with PAF and its metabolic enzymes in healthy volunteers.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Adult; Alcohol Drinking; Antioxidants; Cardiovascular Diseases; Cross-Sectional Studies; Diacylglycerol Cholinephosphotransferase; Diet, High-Fat; Dietary Carbohydrates; Female; Glycemic Index; Greece; Humans; Leukocytes; Male; Middle Aged; Platelet Activating Factor; Principal Component Analysis; Risk; Sex Characteristics; Up-Regulation | 2015 |
Natural antibodies against phosphorylcholine as potential protective factors in SLE.
Topics: Adult; Autoantibodies; Binding, Competitive; Cardiovascular Diseases; Cross Reactions; Endothelium, Vascular; Female; Hemocyanins; Humans; Immunoglobulin G; Intercellular Adhesion Molecule-1; Lupus Erythematosus, Systemic; Middle Aged; Phosphorylcholine; Platelet Activating Factor; Serum Albumin, Bovine; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2008 |
In vitro and in vivo effects of statins on platelet-activating factor and its metabolism.
Topics: Animals; Cardiovascular Diseases; Cells, Cultured; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mesangial Cells; Platelet Activating Factor; Rabbits; Reproducibility of Results; Simvastatin; Statistics, Nonparametric | 2011 |
Coleus forskohlii. Monograph.
Topics: Adenosine Monophosphate; Cardiovascular Diseases; Coleus; Colforsin; Glaucoma; Hypersensitivity; Obesity; Platelet Activating Factor; Psoriasis | 2006 |
Anaphylactic shock depends on PI3K and eNOS-derived NO.
Topics: Anaphylaxis; Animals; Blood Pressure; Cardiovascular Diseases; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Quinoxalines; Serum Albumin, Bovine; Transcription, Genetic | 2006 |
PAF and human cardiovascular disorders.
Topics: Animals; Cardiovascular Diseases; Humans; Platelet Activating Factor | 1995 |
Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Diterpenes; Ginkgolides; Guinea Pigs; Lactones; Lung; Male; Platelet Activating Factor; Respiratory Tract Diseases; Ventricular Function, Left | 1993 |
Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cardiovascular Diseases; Collagen; Dose-Response Relationship, Drug; Endopeptidases; Fibrinolytic Agents; Humans; Leeches; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 2000 |
NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities.
Topics: Asthma; Cardiovascular Diseases; Humans; Lung Diseases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1992 |
Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
Topics: Animals; Body Water; Cardiovascular Diseases; Drug Synergism; Endotoxins; Escherichia coli; Hemodynamics; Lipopolysaccharides; Lung; Lung Diseases; Male; Microscopy, Electron, Scanning; Organ Size; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thromboxane B2; Tumor Necrosis Factor-alpha | 1991 |
[Physiological variants of functional and biochemical indicators of thrombocytes].
Topics: Adenine Nucleotides; Blood Platelets; Cardiovascular Diseases; Circadian Rhythm; Dietary Fats; Female; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Seasons; Sex Factors; Stress, Psychological | 1991 |